EC-131

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameEC-131

Drug Alias Namefolate receptor targeted maytansinoid (Endocyte)folic acid-DM1 conjugate (Endocyte)EC-131

ClassificationSmall molecules > Prodrug > Directed prodrug therapy

Mechanisms of ActionTubulin inhibitors

TargetsTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEndocyte Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEndocyte Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A